Prediction of recovery of myocardial dysfunction after revascularization comparison of fluorine-18 fluorodeoxglucose/Thallium-201 SPECT, thallium-201 Stress-Reinjection SPECT and dobutamine echocardiography

Journal of the American College of Cardiology

Volumn 28, Issue 3, 1996, Pages 558-564

  Bax, Jeroen J ^a,c   Cornel, Jan H ^b   Visser, Frans C ^a   Fioretti, Paolo M ^b   Van Lingen, Arthur ^a   Reijs, Ambroos E M ^b   Boersma, Eric ^b   Teule, Gerrit J J ^a   Visser, Cees A ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; THALLIUM 201;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; EXERCISE TEST; FEMALE; HEART DISEASE; HEART FUNCTION; HUMAN; MALE; PRIORITY JOURNAL; REVASCULARIZATION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 0342483929     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(96)00222-7     Document Type: Article

References (31)

1. 1. Dilsizian V, Bonow RO. Current diagnostic techniques of assessing viability in patients with hibernating and stunned myocardium. Circulation 1993;87:1-20.
2. 2. Tillisch J, Brunken R, Marshall R, et al. Reversibility of cardiac wall motion abnormalities predicted by positron tomography. N Engl J Med 1986;314: 884-8.
3. 3. Vom Dahl J, Eitzman DT, Al-Aouar ZR, et al. Relation of regional function, perfusion and metabolism in patients with advanced coronary artery disease undergoing surgical revascularization. Circulation 1994;90:2356-66.
4. 4. Marwick TH, MacIntyre WJ, Lafont A, Nemec JJ, Salcedo EE. Metabolic responses of hibernating and infarcted myocardium to revascularization. Circulation 1992;85:1347-53.
5. 5. Knuuti MJ, Nuutila P, Ruotsalainen U, et al. The value of quantitative analysis of glucose utilization in detection of myocardial viability by PET. J Nucl Med 1993;34:2068-75.
6. 6. Vanoverschelde JLJ, Wijns W, Depre C, et al. Mechanisms of chronic regional postischemic dysfunction in humans. New insights from the study of noninfarcted collateral-dependent myocardium. Circulation 1993;87:1513-23.
7. 7. Dilsizian V, Rocco TP, Freedman NMT, Leon MB, Bonow RO. Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging. N Engl J Med 1990;323:141-6.
8. 8. Ohtani H, Tamaki N, Yonekura Y, et al. Value of thallium-201 reinjection after delayed SPECT imaging for predicting reversible ischemia ischemia after coronary artery bypass grafting. Am J Cardiol 1990;66:394-9.
9. 9. Bonow RO, Dilsizian V, Cuocolo A, Bacharach SL. Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction. Comparison of thallium scintigraphy with reinjection and PET imaging with 18-F-fluorodeoxyglucose. Circulation 1991;83: 26-37.
10. 10. Dilsizian V, Freedman NMT, Bacharach SL, Perrone-Filardi P, Bonow RO. Regional thallium uptake in irreversible defects. Magnitude of change in thallium activity after reinjection distinguishes viable from nonviable myocardium. Circulation 1992;85:627-34.
11. 11. La Canna G, Alfieri O, Giubbini R, Gargano M, Ferrari R, Visioli O. Echocardiography during infusion of dobutamine for identification of reversible dysfunction in patients with chronic coronary artery disease. J Am Coll Cardiol 1994;23:617-26.
12. 12. Afridi I, Kleiman NS, Raizner AE, Zoghbi WA. Dobutamine echocardiography in myocardial hibernation. Optimal dose and accuracy in predicting recovery of ventricular function after coronary angioplasty. Circulation 1995;91:663-70.
13. 13. Arnese M, Cornel JH, Salustri A, et al. Prediction of improvement of regional left ventricular function after surgical revascularization: a comparison of low-dose dobutamine echocardiography with 201-T1 SPECT. Circulation 1995;91:2748-52.
14. 14. Perrone-Filardi P, Pace L, Prastaro M, et al. Dobutamine echocardiography predicts improvement of hypoperfused dysfunctional myocardium after revascularization in patients with coronary artery disease. Circulation 1995; 91:2556-65.
15. 15. Schelbert HR. Metabolic imaging to assess myocardial viability. J Nucl Med 1994;35 Suppl:8S-14S.
16. 18F-fluorodeoxyglucose using single photon emission computed tomography. Eur Heart J 1993;14:1675-82.
17. 17. Bax JJ, Visser FC, van Lingen A, et al. Relation between myocardial uptake of thallium-201 chloride and fluorine-18 fluorodeoxyglucose imaged with single-photon emission tomography in normal individuals. Eur J Nucl Med 1995;22:56-60.
18. 18. Bax JJ, Cornel JH, Visser FC, et al. The role of fluorine-18-deoxyglucose single photon emission computed tomography in predicting reversibility of regional wall motion abnormalities after revascularization. In: Van der Wall EE, Blanksma PK, Niemeyer MG, Paans AMJ, editors. Cardiac Positron Emission Tomography. Dordrecht (The Netherlands): Kluwer, 1995:75-85.
19. 19. Burt RW, Perkins OW, Oppenheim BE, et al. Direct comparison of fluorine-18-FDG SPECT, fluorine-18-FDG PET and rest thallium-201 SPECT for the detection of myocardial viability. J Nucl Med 1995;36:176-9.
20. 20. Martin WH, Delbeke D, Patton JA, et al. FDG-SPECT: correlation with FDG-PET. J Nucl Med 1995;36:988-95.
21. 21. Jaarsma W, Visser CA, Eenige van MJ, et al. Prognostic implications of regional hyperkinesia and remote asynergy of noninfarcted myocardium. Am J Cardiol 1986;58:394-8.
22. 22. Melin JA, Becker LC. Quantitative relationship between global left ventricular thallium uptake and blood flow: effects of propranolol, ouabain, dipyridamole and coronary artery occlusion. J Nucl Med 1986;27:641-52.
23. 23. Knuuti J, Nuutila P, Ruotsalainen U, et al. Euglycemic hyperinsulinemic clamp and oral glucose load in stimulating myocardial glucose utilization during positron emission tomography. J Nucl Med 1992;33:1255-62.
24. 24. Gropler RJ, Siegel BA, Lee KJ, et al. Nonuniformity in myocardial accumulation of fluorine-18-fluorodeoxyglucose in normal fasted humans. J Nucl Med 1990;31:1749-56.
25. 25. Phelps ME, Hoffman EJ, Selin C, et al. Investigation of [18F]2-fluoro-2-deoxyglucose for the measure of myocardial glucose metabolism. J Nucl Med 1978;19:1311-9.
26. 26. Van Lingen A, Huijgens PC, Visser FC, et al. Performance characteristics of a 511-keV collimator for imaging positron emitters with a standard gamma-camera. Eur J Nucl Med 1992;19:315-21.
27. 27. Bax JJ, Cornel JH, Visser FC, et al. Functional recovery after revascularization predicted by quantitative FDG SPECT [abstract]. Eur J Nucl Med 1995;22:798.
28. 28. Maddahi J, Schelbert HR, Brunken RC, Di Carli M. Role of thallium-201 and PET imaging in evaluation of myocardial viability and management of patients with coronary artery disease and left ventricular function. J Nucl Med 1994;35:707-15.
29. 29. Bashour TT, Mason DT. Myocardial hibernation and "embalment." Am Heart J 1990;119:706-8.
30. 30. Schiller NB, et al., for the American Society of Echocardiography Committee of Standards, Subcommittee on Quantification of Two-Dimensional Echocardiograms. Recommendation for quantification of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr 1989;2:358-67.
31. 31. Edwards WD, Tajik AJ, Seward JB. Standardized nomenclature and anatomic basis for regional tomographic analysis of the heart. Mayo Clin Proc 1981;56:479-97.